Banque Pictet & Cie’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $107K | Sell |
62,121
-4,173
| -6% | -$7.18K | ﹤0.01% | 343 |
|
|
2025
Q1 | $221K | Sell |
66,294
-310,297
| -82% | -$1.03M | ﹤0.01% | 363 |
|
|
2024
Q4 | $2.79M | Buy |
376,591
+54,832
| +17% | +$406K | 0.02% | 191 |
|
|
2024
Q3 | $3.02M | Sell |
321,759
-346,891
| -52% | -$3.26M | 0.02% | 165 |
|
|
2024
Q2 | $5.36M | Sell |
668,650
-20,706
| -3% | -$166K | 0.05% | 140 |
|
|
2024
Q1 | $10.2M | Sell |
689,356
-88,682
| -11% | -$1.31M | 0.1% | 86 |
|
|
2023
Q4 | $6.33M | Buy |
778,038
+144,244
| +23% | +$1.17M | 0.05% | 131 |
|
|
2023
Q3 | $2.88M | Buy |
633,794
+99,636
| +19% | +$453K | 0.03% | 179 |
|
|
2023
Q2 | $3.76M | Sell |
534,158
-138,730
| -21% | -$977K | 0.03% | 182 |
|
|
2023
Q1 | $4.11M | Buy |
672,888
+106,316
| +19% | +$650K | 0.04% | 192 |
|
|
2022
Q4 | $3.62M | Sell |
566,572
-29,040
| -5% | -$186K | 0.04% | 211 |
|
|
2022
Q3 | $5.71M | Sell |
595,612
-88,721
| -13% | -$850K | 0.06% | 163 |
|
|
2022
Q2 | $7.56K | Buy |
684,333
+148,563
| +28% | +$1.64K | 0.07% | 122 |
|
|
2022
Q1 | $8.92M | Buy |
535,770
+1,734
| +0.3% | +$28.9K | 0.07% | 130 |
|
|
2021
Q4 | $10.2M | Buy |
534,036
+467,364
| +701% | +$8.92M | 0.08% | 130 |
|
|
2021
Q3 | $1.64M | Buy |
66,672
+7,552
| +13% | +$186K | 0.02% | 216 |
|
|
2021
Q2 | $1.54M | Buy |
59,120
+41,523
| +236% | +$1.08M | 0.02% | 222 |
|
|
2021
Q1 | $557K | Buy |
+17,597
| New | +$557K | 0.01% | 288 |
|